SYNLAB enters Nigerian market, acquires majority stake in PathCare Nigeria
The transaction with SYNLAB allows PathCare Nigeria the ability to offer its Nigerian customers an extended portfolio of specialised tests.
The transaction with SYNLAB allows PathCare Nigeria the ability to offer its Nigerian customers an extended portfolio of specialised tests.
All content is Copyrighted © 2025 The Premium Times, Nigeria
